The Patent Finder

Conjugates of Biologically Active Molecules to Functionalized Polymers

Quiapeg Pharmaceuticals AB

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 2 of these applications claim priority to application 14/407,580, filed Dec 12, 2014. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 10,383,946Conjugates of Biologically Active Molecules to Functionalized Polymers
In force
 · High confidence
Quiapeg Pharmaceuticals ABIn force
High confidence
US 11,510,989Conjugates of Biologically Active Molecules to Functionalized Polymers
In force
 · High confidence
Quiapeg Pharmaceuticals ABIn force
High confidence
US 10,806,796Conjugates of Biologically Active Molecules to Functionalized Polymers
Lapsed Oct 20, 2024 on the fee record
High confidence
Quiapeg Pharmaceuticals ABLapsed Oct 20, 2024 on the fee record
High confidence
US 10,010,621Conjugates of Biologically Active Molecules to Functionalized Polymers
Lapsed Jul 3, 2026 on the fee record
High confidence
Quiapeg Pharmaceuticals ABLapsed Jul 3, 2026 on the fee record
High confidence
Application 17/974,258Conjugates of Biologically Active Molecules to Functionalized Polymers
Abandoned
Abandoned Dec 1, 2023
Quiapeg Pharmaceuticals ABAbandonedAbandoned Dec 1, 2023
5 of 5 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
2 of these are in force and held by Quiapeg Pharmaceuticals AB.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited